Ms. Nagy is a licensed genetic counselor and Director of Medical Affairs at Guardant Health, Inc. Prior to joining Guardant, she was an Associate Professor in the Department of Clinical Internal Medicine at the Ohio State University James Cancer Hospital. She has over 15 years of experience in counseling patients with hereditary cancer syndromes and extensive experience in translational research, serving as a co-PI on an NCI-funded program project and SPORE. She is a past president of the National Society of Genetic Counselors and continues her leadership role in the NSGC as co-director of the NSGC Leadership Development Program.
Cancer genomic profiling can identify germline and medically actionable mutation(s) in cancer predisposition genes. This can present a complex problem for diagnostics labs because of broader implications regarding the patient’s overall health risk, risk of future cancers, and implications for the patient’s family. This panel discussion will focus on how diagnostics labs are addressing this complexity.